We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Low Vitamin D Levels Related to an Increased Risk of PAD

By Biotechdaily staff writers
Posted on 30 Apr 2008
Low levels of vitamin D may be associated with an increased risk for peripheral arterial disease (PAD), according to a new study.

Researchers at the Albert Einstein College of Medicine (New York; NY, USA) analyzed data from a national survey measuring vitamin D levels in 4,839 U.S. More...
adults, and correlated the results with PAD prevalence. The researchers also measured risk factors for PAD such as cholesterol levels, diabetes, blood pressure (BP), and inflammatory markers such as C-reactive protein, as well as ankle-brachial index, a PAD screening tool that measures blood flow to the legs.

The researchers found that higher levels of vitamin D correlated with a lower incidence of PAD. In the participants with the highest vitamin D levels--more than 29.2 nanograms per milliliter (ng/mL)--only 3.7% had PAD. Among those with the lowest levels--less than 17.8 ng/mL--8.1% had PAD. After adjusting for age, sex, race, and co-existing health problems, the researchers found that adults in the lowest vitamin D group had a 64% higher prevalence of PAD compared to those with the highest vitamin D levels; for each 10-ng/mL lower vitamin D level, there was a 29% higher risk of PAD. The researchers claimed that this does not mean that vitamin D is having a protective effect itself, although this is one hypothesis. It is also possible that higher vitamin D levels may be a marker of other health practices (such as eating a healthier diet or engaging in more physical activity) which could be related to sun exposure. The study was presented at the American Heart Association (AHA) Arteriosclerosis, Thrombosis, and Vascular Biology annual Conference, held during April 2008 in Chicago (IL, USA).

"In animals, vitamin D has anti-inflammatory activity,” said lead author Michal Melamed, M.D., M.H.S., an assistant professor of medicine and epidemiology. "In addition, in mice, vitamin D is a regulator of one of the hormone systems that affects blood pressure. The cells in the blood vessels in the body have receptors for vitamin D, so vitamin D may have direct effects on the vessels, although this has not been fully worked out.”

"Other vitamins have been thought to help prevent cardiovascular disease, such as vitamin E, which did not pan out after being tested in a randomized clinical trial,” added Dr. Melamed. "Therefore, we would not recommend people start taking vitamin D supplements without talking to their doctors. However, we recommend eating a balanced diet. People obtain vitamin D either through exposure to the sun or from foods, especially fish and fortified milk and other fortified foods.”

Vitamin D, or 25-hydroxyl vitamin D, is converted by the body to a hormone that strengthens bones. Severe vitamin D deficiency can cause diseases such as rickets in children. Scientists are only beginning to explore the relationship between 25-hydroxyl vitamin D and cardiovascular disease.


Related Links:
Albert Einstein College of Medicine

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.